Teleflex/$TFX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Teleflex
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Ticker
$TFX
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
14,100
ISIN
US8793691069
Website
Teleflex Metrics
BasicAdvanced
$5.3B
37.39
$3.20
1.09
$1.36
1.14%
Price and volume
Market cap
$5.3B
Beta
1.09
52-week high
$245.46
52-week low
$115.94
Average daily volume
468K
Dividend rate
$1.36
Financial strength
Current ratio
2.277
Quick ratio
1.108
Long term debt to equity
46.723
Total debt to equity
48.96
Dividend payout ratio (TTM)
41.99%
Interest coverage (TTM)
7.14%
Profitability
EBITDA (TTM)
842.883
Gross margin (TTM)
55.98%
Net profit margin (TTM)
4.96%
Operating margin (TTM)
18.84%
Effective tax rate (TTM)
28.88%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.84%
Return on equity (TTM)
3.48%
Valuation
Price to earnings (TTM)
37.385
Price to revenue (TTM)
1.848
Price to book
1.3
Price to tangible book (TTM)
-6.82
Price to free cash flow (TTM)
11.592
Free cash flow yield (TTM)
8.63%
Free cash flow per share (TTM)
1,031.57%
Dividend yield (TTM)
1.14%
Forward dividend yield
1.14%
Growth
Revenue change (TTM)
0.29%
Earnings per share change (TTM)
-48.69%
3-year revenue growth (CAGR)
2.23%
10-year revenue growth (CAGR)
5.16%
3-year earnings per share growth (CAGR)
-32.24%
10-year earnings per share growth (CAGR)
-2.41%
What the Analysts think about Teleflex
Analyst ratings (Buy, Hold, Sell) for Teleflex stock.
Bulls say / Bears say
Teleflex raised its 2024 adjusted profit forecast to $13.80-$14.20 per share, driven by strong demand for surgical procedures utilizing its medical devices. (reuters.com)
The company authorized a $500 million share repurchase program, indicating confidence in its financial position and commitment to returning value to shareholders. (reuters.com)
Teleflex secured two group purchasing agreements with Premier, Inc., effective July 1, 2024, providing Premier members with special pricing on its hemostatic products, potentially expanding its customer base and revenue. (stocktitan.net)
In March 2025, BofA Securities downgraded Teleflex to an 'Underperform' rating, reflecting concerns about the company's future performance. (bovnews.com)
Teleflex's stock price has declined by approximately 28.93% over the past year, indicating potential investor concerns about the company's growth prospects. (stocktitan.net)
The company has faced increased operational costs and restructuring charges, which have impacted profitability and may continue to do so if not effectively managed. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jun 2025.
Teleflex Financial Performance
Revenues and expenses
Teleflex Earnings Performance
Company profitability
Teleflex News
AllArticlesVideos
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewsWire·2 weeks ago
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
GlobeNewsWire·2 weeks ago
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teleflex stock?
Teleflex (TFX) has a market cap of $5.3B as of June 27, 2025.
What is the P/E ratio for Teleflex stock?
The price to earnings (P/E) ratio for Teleflex (TFX) stock is 37.39 as of June 27, 2025.
Does Teleflex stock pay dividends?
Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $1.36 and the yield is 1.14%. Teleflex has a payout ratio of 41.99% on a trailing twelve-month basis.
When is the next Teleflex dividend payment date?
The next Teleflex (TFX) dividend payment date is unconfirmed.
What is the beta indicator for Teleflex?
Teleflex (TFX) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.